S. F. Altekruse, K. A. Mcglynn, L. A. Dickie, and D. E. Kleiner, Hepatocellular carcinoma confirmation, treatment, and survival in surveillance, epidemiology, and end results registries, Hepatology, vol.55, pp.476-482, 1992.

J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers et al., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int. J. Cancer, vol.127, pp.2893-2917, 2010.

K. E. Sherman, S. D. Rouster, R. T. Chung, and N. Rajicic, Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group, Clin. Infect. Dis, vol.34, pp.831-837, 2002.

L. Ryom, J. D. Lundgren, D. Wit, and S. , Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons, AIDS, vol.30, pp.1731-1774, 2016.

P. Marcon, C. V. Tovo, D. A. Kliemann, P. Fisch, and A. A. De-mattos, Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: A retrospective cohort study, World J Gastroenterol, vol.24, pp.613-622, 2018.

F. Kanwal, J. Kramer, S. M. Asch, M. Chayanupatkul, Y. Cao et al., Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

, Gastroenterology, vol.153, pp.996-1005, 2017.

M. Puoti, R. Bruno, and V. Soriano, Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome, AIDS, vol.18, pp.2285-2293, 2004.
DOI : 10.1097/00002030-200411190-00009

N. Bräu, R. K. Fox, and P. Xiao, Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study, J. Hepatol, vol.47, pp.527-537, 2007.

V. Bourcier, M. Winnock, A. Ahmed, and M. , Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir), Clin Res Hepatol Gastroenterol, vol.36, pp.214-221, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00867049

M. Gelu-simeon, R. Sobesky, and S. Haïm-boukobza, Do the epidemiology, physiological mechanisms and characteristics of hepatocellular carcinoma in HIVinfected patients justify specific screening policies?, AIDS, vol.28, pp.1379-1391, 2014.

M. Lewin, M. Gelu-simeon, and M. Ostos, CT and MR Imaging of Hepatocellular Accepted Article Carcinoma (HCC) in HIV-HCV co-infected cirrhotic patients: arguments for a new screening policy, Radiology, vol.277, pp.443-53, 2015.

M. Gelu-simeon, T. Bayan, and M. Ostos, ANRS HC EP 25 PRETHEVIC study group. MELD Score Kinetics in Decompensated HIV+/HCV+ Patients: A Useful Prognostic Tool (ANRS HC EP 25 PRETHEVIC Cohort Study), Medicine, vol.94, p.1239, 2015.

M. A. Loko, D. Salmon, and P. Carrieri, ANRS CO 13 HEPAVIH Study Group. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, BMC Infect Dis, vol.10, p.303, 2006.

J. Trinchet, V. Bourcier, and C. Chaffaut, Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort), Hepatology, vol.62, pp.737-50, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01201948

J. Bruix and M. Sherman, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update, Hepatology, vol.53, pp.1020-1022, 2011.

J. M. Llovet, C. Brú, and J. Bruix, Prognosis of hepatocellular carcinoma: the BCLC staging classification, Semin. Liver Dis, vol.19, pp.329-338, 1999.

V. Mazzaferro, E. Regalia, and R. Doci, Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis, N. Engl. J. Med, vol.334, pp.693-699, 1996.

C. Duvoux, F. Roudot-thoraval, and T. Decaens, Liver transplantation for hepatocellular carcinoma: a model including ?-fetoprotein improves the performance of Milan criteria, Gastroenterology, vol.143, pp.986-994, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00865368

N. Merchante, E. Merino, and J. López-aldeguer, Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain, Clin. Infect. Dis, vol.56, pp.143-150, 2013.

M. D. Hernandez and K. E. Sherman, HIV/hepatitis C coinfection natural history and disease progression, Curr Opin HIV AIDS, vol.6, pp.478-482, 2011.
DOI : 10.1097/coh.0b013e32834bd365
URL : http://europepmc.org/articles/pmc3293393?pdf=render

A. C. Tuyama, F. Hong, Y. Saiman, and C. Wang, Human Immunodeficiency Virus, issue.1

, Infects Human Hepatic Stellate Cells and Promotes Collagen I and Monocyte Chemoattractant Protein-1 Expression: Implications for the Pathogenesis of HIV/Hepatitis C Virus-Induced Liver Fibrosis, Hepatology, vol.52, pp.612-622, 2010.

S. Haïm-boukobza, K. Balabanian, and E. Teicher, Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients, J. Hepatol, vol.59, pp.613-615, 2013.

M. Puoti, R. Rossotti, A. Garlaschelli, and R. Bruno, Hepatocellular carcinoma in HIV hepatitis C virus, Accepted Article 23, vol.6, pp.534-542, 2011.

M. Kudo, O. Matsui, and N. Izumi, Liver Cancer Study Group of Japan. JSH ConsensusBased Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan, Liver Cancer, vol.3, pp.458-68, 2014.

O. Seror, N. 'kontchou, G. Haddar, and D. , Large infiltrative hepatocellular carcinomas: treatment with percutaneous intra-arterial ethanol injection alone or in combination with conventional percutaneous ethanol injection, Radiology, vol.234, pp.299-309, 2005.
DOI : 10.1148/radiol.2341031008

, Accepted Article The ANRS CO13 HEPAVIH Study Group

D. Salmon, F. Dabis, M. Winnock, M. A. Loko, P. Sogni et al., J.Polo Devoto, S.Couffin-Cadiergues

, Clinical Centres (Department/principal investigator

, Maladies Infectieuses/D.Salmon)

C. Pitié-salpétrière,

/. Tropicales and . Ma, Valantin

C. Pitié-salpétrière,

M. Marguerite, Service d'Immuno-Hématologie Clinique-CISIH/I.Poizot-Martin)

, Maladies Infectieuses et, Tropicales/J Chas

. Chu-purpan-toulouse,

, Médecine Interne/L Alric

/. J. Infectiologie and . Durant,

, Hôpital Joseph-Ducuing

A. Chu-saint,

/. K. Tropicales and . Lacombe,

C. Bicêtre,

, Maladies Infectieuses

D. Vittecoq,

, Maladies Infectieuses et Tropicales/C.Duvivier)

A. Co,

, P.Morlat

F. Hôpital and . Suresnes,

. Chu-antoine-béclère, Médecine Interne/J.Polo Devoto

C. Mondor,

, Nantes (Maladies Infectieuses et Tropicales/E.Billaud

. Hôpital-de-la-croix-rousse,

, Maladies Infectieuses et Immunologie Clinique/ F.Bani-Sadr) ; CH de Perpignan (Maladies Infectieuses et, Tropicales/ H.Aumaître)

, CISIH/ D.Rey) Statistical analyses

F. Dabis and L. Wittkop,

, Accepted Article The ANRS CO12 CirVir Study Group Scientific committee

P. Nahon, V. Mahuas-bourcier, J. Zucman-rossi, P. Bedossa, A. Laurent et al.,

, Clinical Centres (Department/participating physicians)

. Chu-jean-verdier, (. Bondy, V. Ganne-carrié, and P. Bourcier, Nahon

, Clichy (D Furand

. Chu-kremlin-bicêtre,

, Angers (P.Calès

, Hôpital Saint-Joseph

, Nancy (J.P.Bronowicki

, Hôpital Archet

, Rennes (D.Guyader

, CH Pays d'Aix

;. V. Chu-jean-minjoz and . Martino,

, Ledinghen

. Chu-hôtel, . Dieu, (. F. Lyon, . Zoulim, and . Merle,

, Hôpital Foch, Suresnes (S.Hillaire

(. T. Chu-caen and . Dao,

, P.Mathurin

. Ch-le-mans,

, JP.Zarski

(. O. Chu-rouen, G. Goria, and . Riachi,

, Toulouse (JM.Péron); service medicine interne CHU Purpan

, Data management and statistical analyses: Françoise Roudot-Thoraval and Richard Layese